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Abstract 
Stable single alpha-helix (SAH) domains are widely distributed in the proteome, including in 
myosins, but their functions are unknown. To test whether SAH domains can act as levers, we 
replaced four of the six calmodulin binding IQ motifs in the levers of mouse myosin 5a (Myo5) with 
the putative SAH domain of Dictyostelium myosin MyoM of similar length. The SAH domain was 
inserted between the IQ motifs and the coiled coil in a Myo5 HMM construct in which the levers 
were truncated from 6 to 2IQ motifs (Myo5-2IQ). Electron microscopy of this chimera (Myo5-2IQ-
SAH) showed the SAH domain was straight and 17 nm long as predicted, restoring the truncated 
lever to the length of wild type (Myo5-6IQ). The powerstroke (of 21.5 nm) measured in the optical 
trap was slightly less than that for Myo5-6IQ but much greater than for Myo5-2IQ. Myo5-2IQ-SAH 
moved processively along actin at physiological ATP concentrations with similar stride and run 
lengths to Myo5-6IQ in in-vitro single molecule assays. In comparison, Myo5-2IQ is not processive 
under these conditions. Solution biochemical experiments indicated that the rear head did not 
mechanically gate the rate of ADP release from the lead head, unlike Myo5-6IQ. These data show 
that the SAH domain can form part of a functional lever in myosins although its mechanical stiffness 
might be lower. More generally, we conclude that SAH domains can act as stiff structural 
extensions in aqueous solution and this structural role may be important in other proteins. 
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Introduction: 
Myosins form a superfamily of motor proteins, which are ubiquitous and responsible for a wide 
range of movement in cells. They all contain three basic components: a motor domain that binds 
DFWLQDQGK\GURO\VHV$73WRJHQHUDWHIRUFHD OHYHUWKDWFRQWDLQV µ,4PRWLIV¶ WRZKLFKOLJKWFKDLQV
(generally calmodulin) bind, and a tail, which directs the cellular function of each myosin. There are 
12 classes of myosins in the human genome, of which 11 are the so-FDOOHG µXQFRQYHQWLRQDO
P\RVLQV¶ (1, 2).  One of the best characterized of the unconventional myosins is myosin 5a 
(henceforth referred to as Myo5).  This dimeric myosin has a long lever (six IQ motifs), which allows 
it to bind to sites on actin 36 nm apart (the spacing of the actin filament helical pseudo-repeat) and 
WKXVµZDON¶VWUDLJKWDORQJDFWLQWDNLQJQPVWHSV(3, 4). Its high duty ratio (3-5) enhances its ability 
to take several steps along actin before falling off (i.e. to behave processively).  
We recently challenged the convention that the myosin lever always consists solely of IQ motifs 
plus their light chains. We showed that the predicted coiled-coil domain of myosin 10 actually forms 
a stable single D-helical (SAH) domain, using a synthetic peptide (6). SAH domains lack the 
hydrophobic seam found in coiled-coil D-helices, and are highly charged (rich in E, K and R 
residues), with many (i, i±4) and (i, i±3) stabilizing intrahelical ionic bonds between either K and E, 
or R and E (2). We further showed that the lever lengths of expressed myosin 10 monomers, or 
much rarer dimers, were consistent with that of the three IQ domains present in this myosin plus 15 
nm contributed by the adjacent SAH domain (6). By sequence homology, we also proposed that 
myosins in classes 6 and 7 and a myosin from Dictyostelium discoideum, MyoM, contain a SAH 
domain rather than coiled coil downstream of their IQ motifs that would increase the size of their 
powerstrokes, and enable them to take 36 nm steps along actin if dimerized. A SAXS analysis of 
myosin 6 has recently suggested that its predicted coiled-coil domain is instead consistent with a 
SAH domain long enough to allow dimeric molecules to take 36 nm steps if artificially dimerized via 
the inclusion of a leucine zipper (7). The putative SAH domains of myosin 7 and MyoM have not yet 
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been studied, although myosin 7a from Drosophila was recently shown to be monomeric as 
expressed in Sf9 cells (8, 9). 
To directly test whether the SAH domain can function as a mechanical lever, we have 
characterized a chimeric Myo5, in which the lever consists of 2 IQ motifs from Myo5 and the 
putative SAH domain from MyoM (Fig. 1). We show this is similar in length to that of parent, wild 
type, Myo5-6IQ molecule. A previously characterized Myo5 with only 2 IQ motifs (Myo5-2IQ) has a 
powerstroke of only 8.9 nm (cf. 25.2 nm in Myo5-6IQ), and unlike the wild type Myo5-6IQ, it is 
processive only at low ATP concentrations (10). The putative SAH domain from MyoM, which has 
the characteristic pattern of charged residues found in this type of domain (Fig. 1D; (2, 6)), has a 
predicted length of 16.8 nm (calculated from the number of residues (112), and the rise per residue 
of an D-helix (0.15 nm). Thus it is slightly longer than the 4 deleted IQ motifs (14.4 nm) that it 
replaces, and the total length of the full-length lever in the Myo5-2IQ-SAH chimera (24 nm) is 
expected to be slightly longer than in the Myo5-6IQ (21.6 nm).  If the SAH domain can function as 
part of the lever, then the properties of this chimera should be similar to those of Myo5-6IQ, and if 
not, its properties should be similar to those of Myo5-2IQ.   
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Results: 
Electron microscopy reveals the SAH domain of MyoM. Electron microscopy, using rotary or 
unidirectional shadowing, confirmed that the putative SAH domain of MyoM did form a SAH domain 
in the GFP-Myo5-2IQ-SAH chimera and not a coiled coil as originally predicted (11, 12). Attempts 
to visualize the chimera by negative staining were unsuccessful, probably because the SAH 
domain is too thin to be delineated by stain. The heads of the chimera are strikingly longer than the 
parent Myo5-2IQ HMM (Fig. 2A) and the SAH domain was revealed as a thin structure between the 
coiled-coil tail and the head domain of the parent Myo5-2IQ HMM in contrast to the lever of Myo5-
6IQ (Fig. 2A). The SAH domain did not become incorporated into the coiled coil, since the 
measured length of the observed coiled coil matches both that predicted for the number of residues 
(175) of Myo5 coiled coil included in the chimera and the length previously measured in Myo5-2IQ 
HMM by this method (Table 1) (6).  
Measurements of the Myo5-2IQ-SAH chimera from the rotary shadowed images indicate that the 
SAH domain extends the lever close to that of Myo5-6IQ.  The length of the motor domain + 2IQs 
was 16.6 ± 2.9 nm, while that of the SAH domain was 17.5 ± 4.6 nm (n=376), consistent with the 
predicted values of 15.2 and 16.8 nm, respectively (Table 1). Inspection of the individual molecules 
indicated that the SAH domain itself is fairly rigid with little bending apparent along its length. The 
mean angle (ĭ) between the SAH domain and the head domain was 180° ± 48° (mean ± S.D., 
n=376) as expected (i.e. an unbroken line between SAH domain and the head). The broad 
distribution of angles (Fig. 2C) could arise both from some flexibility at the junction between the 
SAH domain and IQ6 and from different views of the curved Myo5-2IQ head structure (Fig. 1B). 
Evidence for the latter is the similar breadth of motor-lever angles measured in Myo5-6IQ HMM 
(170.8° ± 37.1° (n=274)).  The angle (ș) between the two SAH domains has a broad non-Gaussian 
distribution centered at ~120°.  This suggests that there is considerable flexibility at the SAH 
domain-coiled coil junction. The range is broader than that measured for Myo5-6IQ HMM (128.6 ± 
40.6° (n=117) for the angle between the levers. 
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Powerstroke size of Myo5-2IQ-SAH chimera is similar to wild type Myo5. Optical tweezers 
measurements showed that the size of the powerstroke for the chimera was close to that of Myo5-
6IQ (Fig. 3F) and much larger than that for Myo5-2IQ.  The powerstroke for Myo5-2IQ-SAH was 
21.5 ± 2.0 nm (mean ± S.E.M.; Fig. 3F) during single (nonprocessive) interactions of Myo5-2IQ-
SAH with actin. Myo5-6IQ and Myo5-2IQ have powerstrokes of 25.2 ± 0.6 nm and 8.9 ± 0.3 nm 
respectively (10). Thus, the SAH domain has increased the mechanically-effective length of the 
lever. The powerstroke of the chimera also exceeds that of a construct containing 4 IQ motifs (15.4 
± 0.5 nm), and is larger than that measured for Myo5-6IQ-2Ala, a construct in which two alanine 
residues were inserted between IQ 3 and 4 of Myo5-6IQ (10.2 ± 0.5 nm) (10). This indicates that 
the lever in the Myo5-2IQ-SAH chimera is stiffer than that of the Myo5-6IQ-2Ala construct. We 
conclude that the SAH domain contributes substantially to the mechanical lever of the chimera. 
Stride length of Myo5-2IQ-SAH chimera is similar to wild type Myo5. We next measured the 
stride lengths of the chimera in in-vitro single molecule motility assays using TIRF microscopy 
(TIRFM). Movement of single molecules of the Myo5-2IQ-SAH chimera on actin was visualized by 
exchanging a Cy3-labeled calmodulin in place of one of the native calmodulins per molecule of the 
chimera. This shows the stride distance of the labelled head (double arrow, Fig. 3A) rather than the 
walking step for each head; movement is observed for every second step taken.  
We found that the stride length of the Cy3-calmodulin-labelled Myo5-2IQ-SAH chimera (Fig. 3C) 
was 70.3 ± 7.5 nm (mean ± SD, n=188). This value is close to that reported in the same type of 
assay for the Myo5-6IQ (75.3 ± 9.3 nm), and much larger than that for Myo5-2IQ (22.9 ± 6.4 nm) 
(13). In addition, the distribution of stride lengths (as indicated by the standard deviation) is similar 
for Myo5-2IQ-SAH and Myo5-6IQ.  In contrast, although the stride length in Myo5-6IQ-2Ala was 
also similar, the distribution of stride lengths was much broader (67.5 ± 20.3 nm) suggestive of 
increased flexibility (10). Thus, the behavior of the chimera in processive runs is consistent with the 
powerstroke measurements in showing that the lever in this molecule is stiffer than that in the 
Myo5-6IQ-2Ala construct.  
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The results from TIRFM assays also showed that inserting the SAH domain into Myo5-2IQ restored 
robust processivity as expected if the SAH domain forms part of the lever. At high (1mM) ATP 
concentrations, the Myo5-2IQ-SAH chimera moved processively in the TIRF assay (Fig. 3B) 
whereas Myo5-2IQ does not and is only weakly processive at low ATP concentrations (10). The run 
length constant for the Myo5-2IQ-SAH chimera obtained from the exponential fit (Fig. 3D) was 1214 
r 52 nm (n=818) at 1mM ATP. This is only slightly lower than that previously measured for Myo5-
6IQ (1380 nm) (13).  Using the run length constant and average step lengths to calculate the 
number of steps taken, the Myo5-2IQ-SAH chimera takes 34 steps of 35.2 nm each compared to 
Myo5-6IQ, which takes 36 steps of 37.7 nm. These values can be compared to those for Myo5-6IQ-
2Ala and 4IQ constructs (10), which take 22 or 30 steps respectively, calculated from their run 
length constants (738 and 763 nm) and step lengths (33.8 and 25.1 nm).  Therefore, the insertion 
of the SAH domain has substantially restored the processivity of Myo5-2IQ. The velocity of the 
Myo5-2IQ-SAH chimera increased with ATP concentration (Fig. 3E) as expected, and it saturated 
at a value of 350 ± 44 nm.s-1 at 300PM ATP. This equates to about 10 forward steps per second. 
ADP release from Myo5-2IQ-SAH chimera on actin is not gated. The results from EM, optical 
trap and TIRFM all indicate that the SAH domain is able to act as a lever in the Myo5-2IQ-SAH 
chimera.  To fully restore function, we might expect that the kinetics of ADP release from the Myo5-
2IQ-6$+FKLPHUDZRXOGEHµJDWHG¶DVIRXQGIRUZLOGW\SH0\R-6IQ HMM. In wild type Myo5-6IQ 
HMM intramolecular mechanochemical gating inhibits the rate of ADP dissociation from the lead 
head by a factor of >30 when the trail head is bound to actin. This helps the molecule to remain 
attached to actin under stall forces, and inhibits futile cycles or backwards steps by the lead head 
(4, 14, 15). 
Measurements of the actin-activated ATPase of the Myo5-2IQ-SAH chimera showed that Vmax was 
9.3 ± 0.8 s-1.head-1 and the KATPase was 2.2 ± 0.7 PM actin.  The value for Vmax compares well to that 
for Myo5-6IQ HMM (10.5 ± 1.5 s-1.head-1). However, the value for the KATPase is 6-7 fold higher than 
the value measured for Myo5-6IQ HMM (0.32 ± 0.09 PM) and is more similar to the value measured 
 8 
for Myo5 S-1 (3.6 ± 1.0PM). This suggests that the two heads in the chimera might not be gated by 
intramolecular strain.  
To investigate whether there is gating present during the ATP hydrolysis cycle of the Myo5-2IQ-
SAH, we performed double-mixing stopped-flow measurements to determine the rate of ADP 
release following the powerstroke using deac-aminoATP as the substrate. Regardless of whether 
ADP or ATP is used as the chase (see methods), we observed a single exponential transient of 
similar magnitude with rate constants of 0.58 s-1 using an ADP chase and 0.52 s-1 using an ATP 
chase for Myo5-2IQ-SAH (Fig. 4A, B).  For comparison, the previously reported transient for Myo5-
6IQ-HMM was a double exponential yielding rate constants of 0.50 s-1 and 0.015 s-1 using an ADP 
chase, and a single exponential yielding 0.36 s-1 using an ATP chase (15,16).  The results for 
Myo5-2IQ-SAH indicate that ADP dissociation from the two heads is not gated.  The lack of gating 
did not originate from a large proportion of single-headed molecules due to cleavage during 
expression or purification, as SDS gels showed a major band for the HMM heavy chain and little 
evidence of S1 or S2. In addition, western blots using anti-FLAG (detecting the C-terminus of the 
heavy chain) labelled the HMM heavy chain ZLWK QR HYLGHQFH RI WKH µ6¶ KHDY\ FKDLQ 0:
aN'DRUµ6$+-6¶KHDY\FKDLQaN'DH[SHFWHGLIWKHVDPSOHFRQWDLQHGVLQJOH-headed HMM 
(Fig. 4C).   The lack of gating is unlikely to arise from binding of the two heads of Myo5-2IQ-SAH to 
different actin filaments, as there was no evidence of bundling of actin filaments in negative stained 
specimens of Myo5-2IQ-SAH bound to actin during ATP hydrolysis (Fig. S1.). 
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Discussion: 
Properties of the Myo5-2IQ-SAH chimera. The addition of the MyoM SAH domain into Myo5-2IQ 
HMM restores its function close to that of the wild type Myo5-6IQ HMM. Myo5 with a lever that 
consists of only 2 IQs is not processive at high ATP concentrations, but inserting the 17 nm SAH 
domain restores the processive behavior, restores the powerstroke close to wild type and allows 
steps along actin with similar lengths to wild type. We did not observe any marked deformation in 
the SAH domains of rotary shadowed molecules, suggesting that it is little deformed by thermal 
forces. We found that the powerstroke size for the chimera is much bigger than that measured for 
the Myo5-6IQ-2Ala construct when measured in the optical trap under a mild load.  Therefore, the 
lever in the chimera must be stiffer than that in the Myo5-6IQ-2Ala construct, in which two alanine 
residues inserted into the middle of the lever (between IQ3 and 4) are known to increase the 
flexibility of the lever. However, ADP release from the lead head is not gated in the chimera 
suggesting that the SAH domain is less stiff than a cDQRQLFDOµ,4FDOPRGXOLQ¶OHYHU 
The powerstroke of the chimera (21.5 nm) was somewhat smaller than that of Myo5-6IQ (25.2 nm), 
however the bending stiffness of the SAH domain is probably less than that of the IQ-calmodulin 
lever (~1500 pN.nm2) (16). This suggests that the powerstroke size of the chimera will be more 
sensitive to load than Myo5-6IQ. The bending stiffness of SAH domains has not yet been directly 
measured, but the SAH domain (a10 nm) in myosin 6 was predicted to have a persistence length of 
about 12 nm (7) and the bending stiffness (EI) of model SAH domains was calculated as 154 
pN.nm2, in part from MD simulations (17), thus about an order of magnitude less than the IQ-
calmodulin lever.  The powerstroke of the chimera was measured at a trap stiffness of 0.015 - 
0.030 pN.nm-1, during which the peak load on the chimeric lever will have been 0.32 - 0.65pN. If the 
OHYHU UHJLRQ DSSUR[LPDWHV WR D FDQWLOHYHU EHQGLQJ PRGH WKHQ LWV VWLIIQHVV ț PHDVXUHG DW D
GLVWDQFH/DORQJLWVOHQJWKLVJLYHQE\ț (,/3. Using EI=154 pN.nm2 for the 17 nm long SAH 
domain, its bending stiffness would be 0.1 pN.nm-1, and the peak load would bend it by 3.4 - 6.9 
nm. This is reasonably consistent with the 3.7 nm reduction in powerstroke observed compared to 
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that measured for Myo5-6IQ.  Therefore, the evidence indicates that the SAH domain can extend 
the lever of myosins in a functional way as we proposed earlier (6). 
Implications of ungated ADP release in the chimera. Unlike Myo5-6IQ, ADP release from the 
lead head in the Myo5-2IQ-SAH chimera was not gated, and yet the chimera can move 
processively. This suggests that gating is not essential for processivity. It has been suggested that 
the processivity of motors increases as the duty ratio (i.e. the fraction of the mechanical cycle that 
the motors spend bound to actin) increases (4). Therefore, the key point is how long the detached 
head takes to carry out its diffusive search for the next binding site on actin. If this search time is 
short, then it is less likely that the remaining attached head will detach before the free head rebinds.  
This search time has been estimated to be about 10ms for Myo5-6IQ (4, 18), and the rate 
constants for ATP hydrolysis on the detached head and for actin activation of phosphate release 
from the lead head (84s-1 and 200s-1 respectively) (19) suggest a similar searching period.  In the 
Myo5-2IQ-SAH chimera, this search time must be short enough for this motor to be processive 
even at high ATP concentrations.  As we found that the powerstroke size of the chimera is similar 
to that of Myo5-6IQ, then the area over which the free head has to carry out its diffusive search, 
and therefore the search time should be similar. The median number of steps (34) we estimate per 
processive run can be used to calculate a duty ratio of 0.855 for the chimera (4). With an ATPase of 
about 10s-1.head-1, this implies an average attachment duration of 85.5ms and search duration of 
14.5ms. 
The observed lack of ADP release gating in the chimera might be expected to reduce its ability to 
perform processive runs, but run lengths are actually only slightly reduced compared to Myo5-6IQ. 
In Myo5-6IQ, ADP release between states 2 to 6 and 3 to 7 (Fig. 5) is inhibited by strain (short 
dotted arrows) and the motor is more likely to proceed to state 4, resulting in forward movement.  
However, in the chimera, in which there is no gating, ADP dissociates at the same rate from trail 
and lead heads (solid arrows in Fig. 5).  As a result moving from state 2, motors will be partitioned 
equally between states 3 and 6 (solid arrows, Fig. 5).  At physiological concentrations of ATP (~1 
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mM) the lead head of state 6 will be expected to bind ATP to produce a futile cycle (6Æ1Æ2), 
which does not produce forward movement but hydrolyzes ATP.  Such futile cycles can account for 
the higher ATPase observed (~10 ATP s-1 head-1) compared to the rate of forward movement in 
TIRFM assays (~5 steps s-1 head-1).  In a small percentage of the cycles, dissociation of ADP from 
either the trail head of state 6 or the lead of state 3 would produce state 7 which could be detached 
by binding ATP to both heads (state 8).  The net effect is a small decrease in the run lengths, which 
is what we observed for the chimera.  Thus, the net effect of the lack of gating is not a large 
reduction in processivity, but in an increase in futile cycles. 
The structural basis of the ungated ADP release in the chimera is not clear. It may be a 
consequence of the lower bending stiffness of the SAH domain compared to the canonical lever 
structure. It is estimated that there is 3.6pN of intramolecular stress exerted on the two heads (in 
opposite directions) when both are attached to actin with ADP in the active site (20). As discussed 
above this would be sufficient to induce considerable curvature into the two SAH domains, and this 
could allow the 2IQ lever of the lead head to execute its powerstroke and open the gate on ADP 
release (see Fig. 5). We have so far been unsuccessful in our attempts to test this conjecture by 
electron microscopy of the chimera-actin complex. For non-muscle myosin 2, there is strong gating 
by actin of ADP release. However, our initial EM has shown the two motors attached to adjacent 
actin subunits with both levers apparently in post-powerstroke orientation (21). Thus, it is not 
necessary to hold the lead head in a pre-powerstroke conformation to inhibit ADP release in myosin 
2, and the structural basis of gating remains obscure. 
In conclusion, the replacement of four IQ motifs in the canonical lever of Myo5 by a similar length of 
SAH domain results in a processive molecule that moves along actin in TIRFM assays and takes 
similar sized stride length to wild type Myo5.  The lack of ADP release gating in this chimera 
supports the idea that such gating is not absolutely required for processivity. The optical trap data 
indicate that the SAH domain augments the working stroke, indicating that it contributes to the 
movements driven by myosins that contain it.  Therefore, myosin levers need to be redefined as the 
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converter plus the IQ motifs/light chains plus the SAH domain, if present. Different myosins take 36 
nm steps using different strategies. Myo5 does this by having a long stiff lever composed of 6 IQ 
motifs.  Myosin 10 dimers may possibly take 36 nm steps since its lever, consisting of 3 IQ motifs 
plus a SAH domain, was shown to be approximately the same length as that of Myo5 (6).  It 
remains to be discovered what the relative merits of these two stratagems are, and how they may 
be important for their cellular roles.  More widely, our data indicate that SAH domains in other 
proteins may act not only as spacers, but also as levers. 
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Methods 
Myosin 5 Chimera: $FKLPHULFµ+00¶OLke construct was made (Myo5-2IQ-SAH) in which residues 
D931 to L1042 (112) residues of the predicted SAH domain of Dictyostelium MyoM were inserted 
downstream of IQ motif 6 in a Myo5-2IQ construct (10) which contains IQ1 and IQ6 (Fig. 1) and 
upstream to 175 residues of coiled-coil sequence from Myo5 (i.e. between E916 and R917 of the 
mouse myosin 5a sequence). The construct was C-terminally FLAG tagged, and expressed and 
purified as described (10).  A second construct was also made in which the coding sequence for 
eGFP was fused to the N-terminus of the chimera (eGFP-Myo5-2IQ-SAH) with the linker sequence 
TCC GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TTT GCG GCC GCA AGG CCT 
encoding 17 amino acids (SGLRSRAQASNFAAARP) between eGFP and Myo5. The cDNA 
encoding MyoM was a kind gift from Dr Thierry Soldati, Department of Biochemistry, University of 
Geneva. 
Electron Microscopy. For metal shadowing EM, the Myo5-2IQ-SAH chimera was typically diluted 
to between 0.1-0.25mg/ml in 0.5M ammonium acetate pH 7.4, 0.5mM MgCl2 and 50% (v/v) 
glycerol, applied to freshly cleaved mica squares and allowed to deposit for approx. 20 s. Excess 
sample was wicked off and the mica centrifuged for 1 minute at 8500 x g. The samples were then 
dried under high vacuum before shadowing. Unidirectional and rotary shadowing used an angle of 
1 in 10. After platinum shadowing, samples were coated with carbon. Replicas were floated off onto 
water and mounted on copper mesh EM grids. Electron micrographs were recorded on a JEOL 
1200EX at a nominal magnification of 30,000x and digitized at a resolution of 0.648 nm/px, 
calibrated using paramyosin filaments (22). 
Optical Trapping. A dual-bead optical tweezers-based force transducer, as described previously 
(23, 24) was used to measure the mechanical and kinetic transitions made by the Myo5-2IQ-SAH 
chimera using the three-bead assay (25, 26).  Details are provided in Supporting Information.  
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TIRF Microscopy. Stride lengths, velocities and run lengths were obtained from TIRF microscopy 
data as described previously (10, 13). Solutions used in these experiments were 20mM MOPS pH 
7.4, 5mM MgCl2, 0.1 mM EGTA, 40 mM KCl, 1mM ATP (varied for ATP dependence 
measurements), 1PM CaM, 50 mM DTT, and an oxygen scavenger system as described (27). 
Transient kinetic experiments. Stopped-flow measurements were performed as described 
previously (19, 28, 29). Details are provided in Supporting Information. Solutions for steady state 
measurements were the same as the in vitro TIRFM assays, except that oxygen scavenger was 
omitted.  
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Figure Legends 
 
 
Figure 1. Diagram of the Myo5-2IQ-SAH chimera and the SAH domain of MyoM. (A) The domain arrangement of the 
chimeric Myo5-2IQ-SAH HMM construct. (B) An atomic model of the chimera molecule shown in spacefill using the same 
color scheme as in (A) with the addition of bound CaM molecules shown in orange.  The construction of this model is 
described in Supporting Information.  (C) The sequence in the chimera from the start of IQ1 to the start of the coiled-coil 
domain in Myo5a, to show the boundaries (arrowed) between Myo5a sequence (lower case) and the inserted MyoM SAH 
domain (blue, upper case). The original Myo5-2IQ construct used to generate the chimera has been described previously 
(10). (D) A heptad net representation of the MyoM SAH domain (upper case) and the first 27 residues of the coiled coil of 
Myo5 HMM (lower case). The helix has been cut beside one of the seven 18/1 helices (that would be designated a-g in 
an D-helical coiled coil) and opened flat to give a 2-D representation of the amino acid residues and their potential 
interactions in the helix, the N-terminus at the top; acidic residues are shown in red, basic in blue, all others in black. The 
preferred ionic interactions (see (2)) are shown as solid lines. In addition alternative/other interactions are shown as 
dotted lines. Every 7th residue is repeated on the right of the plot (in brackets) so that all interactions can be shown. The 
grey dashed lines indicate the path of the polypeptide backbone; the green dotted line defines the orientation of the D-
KHOL[ D[LV 7KH OLJKW JUH\ FLUFOHV LQGLFDWH µD¶ SRVLWLRQV DQG WKH GDUN JUH\ VTXDUHV LQGLFDWH µG¶ SRVLWLRQV WKDW IRUP WKH
hydrophobic seam in the coiled coil of myosin 5. The last few residues of the SAH domain (upper case) could, in principle, 
form a coiled coil in register with the coiled coil of Myo5 HMM, but there is no hydrophobic seam in the majority of the 
SAH domain, suggesting that it would not form coiled coil. 
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Figure 2. Electron Micrographs and analysis of rotary shadowed molecules of the Myo5-2IQ-SAH chimera. (A) A 
gallery of single molecules of rotary shadowed Myo5-6IQ and Myo5-2IQ, together with those for GFP-Myo5-2IQ-SAH 
HMM chimera as seen in either rotary or unidirectional shadowing. The arrows indicate the positions of the SAH domains 
in a molecule of the chimera. Scale bar 25 nm. (B) Diagram of the chimera showing how measurement of the angles 
between domains was carried out.  Red dotted lines indicate the lines between which the angles were measured between 
the Myo5-2IQ head and the SAH domain (ĭ, and between the SAH domains (ș. To measure the angles for each 
molecule, SPIDER was used to select the tip of the head, head-SAH junction, SAH-SAH junction and the end of the 
coiled coil in the order shown. The angles were always measured in the anti-clockwise direction as indicated by the 
arrows. (C) Distribution of the angles for the chimera, as indicated in part (B) (black) and for Myo5-6IQ (red). 
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Figure 3. Stride length data for Myo5-2IQ-SAH chimera from TIRF microscopy and FIONA, and powerstroke 
measurements from optical trap assays. (A) Cartoon showing the movement that is measured for singly-labelled 
heads, in this assay. (B) Example traces of stride length data for molecules that are labelled by Cy3 calmodulin bound to 
a single head show that the Myo5-2IQ-SAH chimera is able to move processively along actin. Because movement is 
stochastic, velocities can vary significantly even within a single run. (C) Histogram of stride lengths fitted with a Gaussian 
distribution for Cy3 labelled chimera with a label on one heads.  The mean value is 70.3 ± 7.5 nm (n=188). Experiments 
were performed using 300 nm ATP. (D) Run lengths at 1mM ATP (40mM KCl) for the Myo5-2IQ-SAH chimera. N=188, 
and the run length constant is 1214 r 52 nm.  The line is an exponential fit to the data. (E) The ATP dependence of 
velocity of the Myo5-2IQ-SAH chimera on actin in TIRF assays. N=40-80 for each measurement. (F) The distribution of 
powerstroke displacements measured for Myo5-2IQ-SAH chimera in the optical trap, fitted by a Gaussian distribution with 
a mean value of 21.5 nm.  The stiffness of the trap (0.015 ± 0.030 pN.nm-1) implies the stroke is developed against a 
force of 0.3 ± 0.7 pN. The breadth (S.E.M. = 2.0 nm) largely derives from the imposed sine wave oscillation imposed on 
the actin filament (see Methods). 
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Figure 4. Product dissociation from the acto-Myo5-2IQ SAH-ADP-Pi complexes.  (A) 0.4 µM Myo5-2IQ-SAH chimera 
was mixed with 0.5 µM deac-aminoATP, held for 20 s in a delay line, then mixed with hexokinase-glucose treated 
phalloidin-actin and 2 mM ADP.  Experimental conditions: 40 mM KCl, 10 mM MOPS, 3 mM MgCl2, 1 mM EGTA, 1 mM 
DTT pH 7.5, 20°C. Final concentrations in the cell: 0.11 µM Myo5-2IQ-SAH active sites, 0.14 µM deac-aminoATP, 11.1 
µM actin, and 1.1 mM ADP. The solid line through the data is the best fit to a single exponential equation: I(t) = 0.079e-
0.58t
 + C. (B) experimental conditions were similar to those in (A) except that a 2 mM ATP chase replaced ADP: I(t) = 
0.080e-0.52t + C. (C) SDS gel and western blot (using an anti-FLAG antibody) of the Myo5-2IQ-SAH chimera used in these 
experiments. The major band on the gel and the blot shows that the purified protein mainly consists of full-length 
molecules. Two different loadings (10 Pg and 30 Pg) of protein were used in the blot.  
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Figure 5.  Cartoon of the principal states of the ATP hydrolysis pathway of actin-Myo5-2IQ-SAH. T=ATP, D=ADP, 
P=phosphate. In the levers, the 2 IQ motifs with bound calmodulins are shown as ellipses, and the SAH domain by a blue 
rod, which is shown curved where it is distorted by intramolecular stresses. In wild type Myo5-6IQ, ADP dissociation from 
the lead head (converting state 2 to 6, rate constant k2,6) is much slower than from the trail head and the principal 
pathway is the processive mechanism (1Æ2Æ3Æ4Æ5Æ1; gray shaded area) where one step is made for each ATP 
molecule hydrolyzed.  ADP dissociation from the trail head (2Æ3) is rate limiting and the other steps on the processive 
path are at least 10-fold faster. Side paths that might lead to dissociation of wild type Myo5-6IQ occur only rarely because 
ADP dissociates mainly from the trail head, i.e. k2,3 >> k2,6  and k3,4 >> k3,7.  Runs terminate mainly by release of the 
attached head (5Æ9Æ10) during the search phase of the cycle (5Æ1).  For the Myo5-2IQ-SAH chimera, ADP 
dissociation from the trail and lead heads occur at the same rate (k2,3 § k2,6) and state 2 thus proceeds equally to states 3 
DQG'LVVRFLDWLRQRI$'3IURPWKHOHDGKHDGZRXOGPRVWO\OHDGWRD³IXWLOHF\FOH³Æ1Æ2; blue shaded area) in which 
the lead head would consume a molecule of ATP without producing movement along actin.  Processivity would be 
decreased slightly by the dissociation (7Æ8) that would occur upon state 7 binding two molecules of ATP, but usually 
binding of ATP to state 7 would allow a return to state 3 of the cycle. Short dotted arrows between 2 and 6 and between 3 
and 7 indicate the slower rate of release of ADP from the lead head of Myo5-6IQ, compared to the chimera (solid arrows). 
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Table Legends 
Table 1. 
 Motor + 
2IQ 
domains 
SAH 
domain  
Motor + IQ 
+ SAH 
domain 
Coiled-coil 
domain 
Expected 
Length (nm) 15.2 16.8 32.0 26.0 
Measured 
Length (nm) 16.6 ± 2.9 17.5 ± 4.6 34.1 ± 5.1 25.9 ± 6.7 
 
 
Table 1: Average length measurements of chimera molecules from rotary shadowed preparations compared to expected 
lengths.  N=376 molecules except for coiled-coil domain measurements, for which n=188.  The motor is expected to be 8 
nm long, and 2 IQ domains, 7.2 nm long, making the total expected length of motor + 2IQ to be 15.2 nm.  Values shown 
are mean ± S.D.  
 
